RPS27AP5: A Promising Drug Target / Biomarker (G100271374)

Target Name: RPS27AP5

NCBI ID: G100271374

RPS27AP5

Other Name(s): ribosomal protein S27a pseudogene 5 | RPS27A_1_141 | Ribosomal protein S27a pseudogene 5

RPS27AP5: A Promising Drug Target / Biomarker

The RPS27AP5 gene is located on chromosome 16 and encodes for a protein known as RPS27-associated protein 5. This protein is a key regulator of the Replication-associated protein 2 (RAP2) complex, which is involved in the regulation of DNA replication and repair. The RPS27AP5 gene has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The RPS27-associated protein 5 (RPS27AP5) gene has four known splice variants, which result in the production of four different proteins with different sizes and functions. These proteins are RPS27AP5-long, RPS27AP5-middle, RPS27AP5-short, and RPS27AP5-longer. The RPS27AP5 protein is a 22kDa protein that plays a critical role in the regulation of DNA replication and repair.

The RPS27AP5 gene is expressed in various tissues and cells, including the brain, spinal cord, heart, kidney, liver, and gut. It is highly expressed in the brain, where it is the most abundant protein in the neuron-associated proteome. The RPS27AP5 protein is also expressed in the liver, where it is involved in the regulation of DNA replication and repair.

The RPS27AP5 gene has been associated with a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that high levels of RPS27AP5 are associated with an increased risk of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, the RPS27AP5 gene has been shown to be involved in the regulation of cancer cell growth and survival, which could make it an attractive target for cancer therapies.

The RPS27AP5 protein is also a potential biomarker for several diseases. The expression of RPS27AP5 has been shown to be elevated in the brains of individuals with Alzheimer's disease, which could be used as a diagnostic biomarker for this disease. Additionally, the RPS27AP5 protein has been shown to be involved in the regulation of pain perception, which could make it an attractive target for pain therapies.

The discovery of the RPS27AP5 gene and its associated proteins has important implications for our understanding of the regulation of DNA replication and repair. The RPS27AP5 gene is a potential drug target and biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of the RPS27AP5 gene in these diseases and to develop effective therapies.

Protein Name: Ribosomal Protein S27a Pseudogene 5

The "RPS27AP5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS27AP5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets